Form 4: AtriCure Director Sven Wehrwein Acquires Shares Through Restricted Stock Award

Director Sven Wehrwein acquired 7,788 shares of AtriCure, Inc. through a restricted stock award that vests in one year.

Summary

• On May 13, 2024, Sven Wehrwein, a director of AtriCure, Inc., acquired 7,788 shares of common stock.
• The acquisition was made through a Restricted Stock Award under the company's 2023 Stock Incentive Plan.
• The shares will vest on the one-year anniversary of the grant date.
• Following the transaction, Wehrwein beneficially owns 28,973 shares of AtriCure common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of shares by a director is generally viewed favorably, indicating confidence in the company's prospects. The restricted stock award aligns the director's interests with those of the shareholders.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.
• The restricted stock award aligns the director's interests with those of the shareholders, encouraging long-term value creation.

Future Outlook

The restricted stock award suggests a commitment to long-term value creation, as the shares vest after one year.

Industry Context

Stock awards are a common practice in the industry to incentivize and retain key personnel, aligning their interests with those of the shareholders.

Stakeholder Impact

• Shareholders may view the director's stock acquisition positively, as it signals confidence in the company's future performance.
• Employees may be motivated by the fact that management is incentivized to improve the company's performance.

Key Dates